Volume 28, Number 6—June 2022
Dispatch
Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain
Table 1
Settings |
Omicron |
Delta |
Difference, % (95% CI) |
|||||||
Index cases |
Close contacts |
Secondary cases |
SAR, % (95% CI) |
Index cases |
Close contacts |
Secondary cases |
SAR, % (95% CI) |
|||
Global | 333 | 1,126 | 443 | 39.3 (36.5–42.2) |
1,403 | 7,013 | 1,846 | 26.3 (25.3–27.4) |
13† (9.9–16.1) |
|
Unvaccinated index case-patient | 210 | 655 | 269 | 41.1 (37.4–44.9) |
535 | 2,876 | 895 | 31.1‡ (29.5–32.8) |
10† (5.7–14.2) |
|
Vaccinated index
case-patient |
111 |
436 |
159 |
36.5 (32.1–41.1) |
829 |
3,904 |
910 |
23.3‡ (22–24.7) |
13.2† (8.3–18) |
|
Household | 287 | 533 | 263 | 49.4 (54–53.6) |
1,095 | 2,350 | 1,129 | 48 (46–50) |
1.3 (−3.4 to 6) |
|
Unvaccinated index case-patient | 187 | 354 | 171 | 49.4 (44.2–54.7) |
450 | 1,118 | 595 | 53.2‡ (50.3–56) |
−3.8 (−9.8 to 2.2) |
|
Vaccinated index
case-patient |
91 |
171 |
85 |
49.7 (42.3–57) |
622 |
1,198 |
519 |
43‡ (40.5–46) |
6.4 (−1.6 to 14.4) |
|
Social | 143 | 524 | 160 | 30.5 (26.8–34.6) |
836 | 4,153 | 672 | 16.2 (15.1–17.3) |
14.4† (10.3–18.5) |
|
Unvaccinated index case-patient | 76 | 283 | 88 | 31.1 (26–36.7) |
315 | 1,640 | 284 | 17.3 (15.6–19.2) |
13.8† (7.9–19.7) |
|
Vaccinated index
case-patient |
61 |
224 |
64 |
28.6 (23.1–34) |
495 |
2,351 |
368 |
15.7 (14.2–17.2) |
12.9† (6.6–19.3) |
|
Occupational | 29 | 58 | 18 | 31 (20.6–43.8) |
148 | 411 | 43 | 10.5 (7.93–13.8) |
20.6† (7.3–33.8) |
|
Unvaccinated index case-patient | 14 | 22 | 8 | 36.4 (19.7–57) |
39 | 97 | 16 | 16.5‡ (10.4–25.1) |
20.1 (−0.04 to 44.1) |
|
Vaccinated index case-patient | 14 | 34 | 10 | 29.4 (16.8–46.1) |
105 | 298 | 21 | 7‡ (4.7–10.5) |
22.4† (5.1–40) |
*SAR, secondary attack rate. †p<0.001. ‡Differences between vaccinated and unvaccinated persons within same-variant context.
Page created: March 23, 2022
Page updated: May 22, 2022
Page reviewed: May 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.